10% Annual Rate Level Distribution Policy Conditional Tender Offer for 10% of Outstanding SharesNEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Japan Smaller Capitalization Fund, Inc. (the “Fund”) (NYSE: JOF) today announced that its Board of Directors (the “Board”) has approved two initiatives aimed at addressing the Fund’s trading discount. These initiatives include a level distribution plan and a conditional tender offer. The Board believes these actions reflect the Fund’s ongoing commitment to enhancing sha ...

NEWTOWN, Pa., June 06, 2025 (GLOBE NEWSWIRE) -- Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving Humana Inc. (“Humana”) (NYSE: HUM), resulting from allegations of providing potentially misleading business information to the investing public. If you have non-public information that could assist in the Humana investigation, or if you are a Humana investor who suffered a loss and would like to learn more, you can provide your information HERE. You can also con ...

Core Viewpoint - Robbins LLP has initiated a class action lawsuit on behalf of investors who acquired Reckitt Benckiser Group PLC American Depository Shares (ADSs) between January 13, 2021, and July 28, 2024, alleging that the company misled investors regarding the safety of its Enfamil baby formula [1][2]. Allegations - The lawsuit claims that Reckitt failed to inform investors and consumers about the increased risk of necrotizing enterocolitis (NEC) in preterm infants consuming its cow's milk-based formula, Enfamil, and the potential negative impact on sales and legal exposure [2]. - A jury in Illinois awarded $60 million in a case against Mead Johnson, finding negligence in failing to warn about the risks associated with cow's milk-based formula, which led to a significant drop in Reckitt's ADS price [3]. - Following a similar case in Missouri, where Abbott Laboratories was found liable for NEC-related damages, Reckitt's ADS price also experienced a notable decline [4]. Class Action Participation - Shareholders interested in serving as lead plaintiffs in the class action must file a motion by August 4, 2025, but participation is not required to be eligible for recovery [5].

Core Viewpoint - Integral Metals Corp. has successfully closed a non-brokered private placement offering of common shares, raising gross proceeds of US$400,000 at a price of US$0.70 per share [1][2]. Group 1: Private Placement Details - The private placement consists of common shares priced at US$0.70 each, resulting in total gross proceeds of US$400,000 [1]. - The net proceeds from the private placement will be allocated for expenditures on mineral exploration properties and general working capital [2]. - All securities issued under the private placement are subject to a hold period of four months and one day [2]. Group 2: Company Overview - Integral Metals Corp. is engaged in mineral exploration for critical minerals, including gallium, germanium, and rare earth elements, aiming to contribute to the development of a domestic supply chain for these minerals [4]. - The company holds properties in mining-friendly jurisdictions in Canada and the USA, including the Northwest Territories, Manitoba, and Montana, where it has received regulatory support for its exploration efforts [4].

Core Viewpoint - Lululemon is facing challenges due to economic factors, including tariffs imposed by President Trump and reduced consumer spending, leading to a decline in sales growth and customer dissatisfaction [1][7][12]. Company Performance - The company reported only a 1% year-over-year increase in sales, falling short of the 3% forecast, indicating a struggle to maintain growth amidst economic pressures [4]. - Lower store traffic in the Americas has been attributed to economic uncertainty, inflation, and changes in discretionary spending, affecting even loyal customers [2][7]. Pricing Strategy - Lululemon plans to implement modest price increases on a small portion of its product assortment in response to rising costs due to tariffs [5][11]. - The company is negotiating with vendors to mitigate the impact of tariffs on its pricing strategy [9][11]. Supply Chain and Tariffs - A significant portion of Lululemon's products is sourced from Vietnam (40%) and China (28%), both of which have been affected by tariffs, leading to increased costs for the company [8][14]. - The company attributes its challenges to these tariffs, particularly on goods manufactured in the affected countries [8][12]. Customer Sentiment - There is notable backlash from customers regarding the pricing and manufacturing decisions, with many expressing dissatisfaction on social media [9][11]. - Critics argue that the brand's reliance on foreign manufacturing and high prices is detrimental to its reputation and sales [12][13].

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, June 06, 2025 (GLOBE NEWSWIRE) -- Pan American Energy Corp. (CSE: PNRG | FRA: SS60) (“Pan American” or the “Company”) announces, further to its news release of May 29, 2024, that it has issued, 205,841 common shares in the capital of the Company (the “Settlement Shares”), at a deemed value of $0.20 per Settlement Share, in full and final settlement of accrued and outstanding debt to certain c ...

Core Insights - Meta's Reality Labs could either achieve significant success or be remembered as a "legendary misadventure" by 2025, with the market being the ultimate judge of its potential [1] - The year 2023 is seen as pivotal for Meta, especially with the successful launch of Ray Ban AI glasses, which have sold over 2 million pairs since their debut in October 2023 [2][4] - Competition is intensifying as other tech giants like Google and Apple are also entering the smart glasses market, with Google partnering with Gentle Monster and Warby Parker, and Apple planning to release its own smart glasses in 2026 [3] Market Dynamics - The market's adoption of Meta's AR and VR products is crucial for driving industry standardization, despite the competition from other incumbents [4] - Meta's CTO emphasizes that the hardware market often lags behind, indicating the importance of early indicators and internal confidence in product execution [7] Execution Focus - The company aims to concentrate on executing its plans rather than being overly concerned with competitors, as many companies fail due to poor execution rather than competition [8] - By the end of 2023, the company will assess whether it has successfully executed its plans, with a longer-term evaluation expected in five years [9]

Group 1 - Tenaris S.A. announced a Share Buyback Program covering up to USD 1.2 billion, with a non-discretionary buyback agreement with a primary financial institution [1][2] - The buyback program will be executed in compliance with applicable regulations, allowing purchases during closed periods [2] - The first tranche of the program will cover up to USD 600 million and will commence on June 9, 2025, ending no later than December 8, 2025 [3] Group 2 - Ordinary shares purchased under the program will be cancelled in due course, following the authority granted by the general meeting of shareholders held on May 6, 2025 [3] - Tenaris is recognized as a leading global supplier of steel tubes and related services for the energy industry and other industrial applications [5]

Company Overview - SelectQuote is a direct-to-consumer insurance platform that offers health, life, auto, and home insurance policies, as well as medication management services through its SelectRx pharmacy division [3] Allegations and Legal Issues - The Department of Justice filed a False Claims Act complaint against SelectQuote on May 1, 2025, alleging the company received millions of dollars in kickbacks from Humana in exchange for specific Medicare Advantage plan enrollments [4] - The complaint claims SelectQuote maintained a sales division that exclusively offered Humana policies and directed a significant portion of its business to Humana [4] Market Reaction - Following the filing of the complaint, SelectQuote's stock price fell by $0.61 per share, or 19.2%, closing at $2.56 per share on May 1, 2025 [5]

Core Viewpoint - Palantir Technologies has transformed from a slow-growth, unprofitable company to a fast-growing, highly profitable business, largely due to the launch of its Artificial Intelligence Platform (AIP) [2] Group 1: Company Performance - Since the start of 2023, Palantir's stock has returned nearly 2,000% [2] - The company now trades at a price-to-sales ratio of 105, indicating significant multiple expansion [3] - Palantir's revenue growth was 39% in its most recent quarter, suggesting strong ongoing performance [10] Group 2: Market Valuation and Predictions - Palantir's market cap has topped $300 billion, making it the most valuable pure-play software company [4] - Analyst Dan Ives predicts Palantir could reach a valuation of $1 trillion in two to three years, raising his price target from $120 to $140 [6][7] - The stock's current valuation presents challenges to achieving the $1 trillion goal, as it would still be considered expensive even with a 75% reduction in price-to-sales valuation [11] Group 3: Government Relations and Growth Drivers - The Trump administration has expanded the federal government's relationship with Palantir, encouraging agencies to share data using its platforms [9] - The scalability of Palantir's subscription software model and its history of expanding operating margins could lead to faster growth on the bottom line [11] - The broader demand for AI and the federal government's embrace of Palantir's services contribute to strong business prospects [12]